A recall of certain batches of GlucaGen HypoKits, used for the emergency treatment of severe low blood glucose, was ordered by the country’s drugs’ watchdog today.
The reason for the recall is that in a small number of units (0.006% approx.) the syringe needle has become detached from the syringe. Units with a detached needle cannot be used to prepare the medicine for administration.
The Health Products Regulatory Authority (HPRA) said it is advising patients and carers to check the batch number on any GlucaGen Hypokit units they may have at home or in their possession and to return any of the affected product to their pharmacist where a replacement will be provided.
GlucaGen HypoKit is packaged with a syringe containing sterile water for injection which is used to prepare the medicine for use.
They are used in emergency situations to treat severe hypoglycaemia in children and adults with diabetes mellitus.
While a very small number of units are likely to be impacted, a delay in emergency treatment could have significant health consequences and, therefore, units from affected batches should not be used and should be returned to the dispensing pharmacy where a replacement will be provided.
Two batches of Novo Nordisk GlucaGen HypoKit and two batches of PCO Manufacturing GlucaGen Hypokit are being recalled in Ireland and this represents a total of 8,064 units.
The affected batch numbers, which are printed on the product label along with an expiry date, are as follows:
Patients and carers who have a GlucaGen Hypokit with a batch number which is not mentioned above, do not need to return the unit to their pharmacy.
The HPRA will closely monitor the recall and provide further updates as necessary on www.hpra.ie
How to Identify the Batch Numbers
Novo Nordisk GlucaGen HypoKits:
PCO Manufacturing GlucaGen HypoKits: